Systemic cardiovascular complications in patients with long-standing diabetes mellitus: Comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography

Investigative Radiology

Volumn 44, Issue 4, 2009, Pages 242-250

  Weckbach, Sabine ^a   Findeisen, Hannes M ^b   Schoenberg, Stefan O ^a   Kramer, Harald ^a   Stark, Renee ^c   Clevert, Dirk A ^a   Reiser, Maximilian F ^a   Parhofer, Klaus G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Atherosclerotic disease; Cumulative disease burden; Diabetes mellitus; Prevalence rates; Whole body MRI MRA

Indexed keywords

GADODIAMIDE;

ADULT; ANGIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DISEASE DURATION; FEMALE; HEART FUNCTION; HEART INFARCTION; HUMAN; IMAGING SYSTEM; KIDNEY ARTERY STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; THREE DIMENSIONAL IMAGING;

CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; REFERENCE STANDARDS; TIME FACTORS;

EID: 67349267099     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31819a60d3     Document Type: Article

References (40)

1. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med. 2000;342:1040-1042.
2. IDF. International Diabetes Federation. Available at: http://www.idf.org. Accessed 2007.
3. Association AD. Diabetes News. Available at: www.diabetes.org. Accessed 2007.
4. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet. 2001;357:1086-1091.
5. Nael K, Fenchel M, Saleh R, et al. Cardiac MR imaging: new advances and role of 3T. Magn Reson Imaging Clin N Am. 2007;15:291-300.
6. Kramer H, Schoenberg SO, Nikolaou K, et al. Cardiovascular screening with parallel imaging techniques and a whole-body MR imager. Radiology. 2005; 236:300-310.
7. Rainer J. Diabetes 2001 vital statistics. American Diabetes Association. Available at: http://www.diabetes.org. Accessed 2001.
8. Thomsen HS. ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol. 2007;17:2692-2696.
9. NKF. National Kidney Foundation. Available at: http://www.kidney.org/ professionals/kdoqi/guidelines/. Accessed 2007.
10. Wintersperger BJ, Reeder SB, Nikolaou K, et al. Cardiac CINE MR imaging with a 32-channel cardiac coil and parallel imaging: impact of acceleration factors on image quality and volumetric accuracy. J Magn Reson Imaging. 2006;23:222-227.
11. Huber AM, Schoenberg SO, Hayes C, et al. Phase-sensitive inversionrecovery MR imaging in the detection of myocardial infarction. Radiology. 2005;237:854-860.
12. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
13. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
14. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
15. Ganguli S, Pedrosa I, Smith MP, et al. Low dose pedal magnetic resonance angiography at 3 Tesla with time-resolved imaging of contrast kinetics: a feasibility study. Invest Radiol. 2008;43:650-655.
16. Meissner OA, Rieger J, Weber C, et al. Critical limb ischemia: hybrid MR angiography compared with DSA. Radiology. 2005;235:308-318.
17. Berg F, Bangard C, Bovenschulte H, et al. Feasibility of peripheral contrastenhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography. Invest Radiol. 2008; 43:642-649.
18. Comte A, Kastler B, Laborie L, et al. Using a contrast-enhanced imaging sequence at 3-minute delay in 3-T magnetic resonance imaging for acute infarct evaluation. Invest Radiol. 2008;43:669-675.
19. Rominger MB, Bachmann GF, Pabst W, et al. Left ventricular heart volume determination with fast MRI in breath holding technique: how different are quantitative heart catheter, quantitative MRI, and visual echocardiography? [in German]. Rofo. 2000;172:23-32.
20. Thiele H, Nagel E, Paetsch I, et al. Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging. 2001;14:362-367.
21. Messroghli DR, Bainbridge GJ, Alfakih K, et al. Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology. 2005;235:229-236.
22. Schweitzer ME, Morrison WB. MR imaging of the diabetic foot. Radiol Clin North Am 2004;42:61-71, vi.
23. Norman PE, Davis WA, Bruce DG, et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2006;29:575-580.
24. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921-929.
25. Wackers FJT, Young LH, Inzucchi SE, et al. Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study. Diabetes Care. 2004;27:1954-1961.
26. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia. 2002;45:S13-S17.
27. Ebeling Barbier C, Bjerner T, Hansen T, et al. Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosis. Radiology. 2007;245:103-110.
28. Christiansen JP, Edwards C, Sinclair T, et al. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. Am J Cardiol. 2006;97:768-771.
29. Kwong RY, Sattar H, Wu H, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118:1011-1020.
30. Schmidt R, Fazekas F, Kleinert G, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol. 1992;49: 825-827.
31. Hansen T, Ahlstrom H, Wikstrom J, et al. A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors. Eur Radiol. 2008;18:1174-1180.
32. Mukherjee D, Eagle KA, Kline-Rogers E, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2007;100:1-6.
33. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197-1206.
34. Espinola-Klein C, Rupprecht HJ, Blankenberg S, et al. Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions [in German]. Z Kardiol 2004;93(suppl 4): IV48-IV55.
35. Lanzer P. Vascular multimorbidity in patients with a documented coronary artery disease. Z Kardiol. 2003;92:650-659.
36. Haffner SM. Epidemiology of type 2 diabetes: risk factors. Diabetes Care. 1998;21(suppl 3):C3-C6.
37. American Diabetes Association. Standards of Medical Care in Diabetes-2007. Diabetes Care. 2007;30:S4-S41.
38. Grover SA, Lowensteyn I, Joseph L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP Study: a Randomized Controlled Trial. Arch Intern Med. 2007;167:2296-2303.
39. Goehde SC, Hunold P, Vogt FM, et al. Full-body cardiovascular and tumor MRI for early detection of disease: feasibility and initial experience in 298 subjects. Am J Roentgenol. 2005;184:598-611.
40. Herborn CU, Vogt FM, Goyen M, et al. Cardiovascular whole-body MRI: possibilities and limitations in prevention [in German]. Radiologe. 2004;44: 826-834.